Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Research seeks to reduce impact of whooping cough

Research seeks to reduce impact of whooping cough in NZ infants

Dr Helen Petousis-Harris from The University of Auckland has been awarded funding for a research project that will investigate the effectiveness of maternal booster immunisation on the incidence of whooping cough in infants.

The project is being funded by the Health Research Council of New Zealand and the Ministry of Health through the ‘Pertussis booster immunisation in pregnancy’ partnership.

Whooping cough (also known as pertussis) is a highly infectious disease that is transmitted by coughing and sneezing. Pertussis can affect all age groups; however, it is most common in children. It can be especially severe in infants under 12 months, leading to pneumonia, breathing problems, and in rare cases, brain damage, convulsions and death. Infants too young to vaccinate are particularly vulnerable.

Despite the immunisation against pertussis, whooping cough remains a disease difficult to control in the general population and outbreaks continue to occur.

As such, immunisation in pregnancy and post-partum have both been recommended by the Ministry of Health. From 1 January 2013, pregnant women between 28 and 38 weeks gestation have been able to receive a whooping cough booster vaccination for free during outbreaks. Transfer of antibodies through the placenta in pregnancy is expected to offer some passive protection until the infant is protected by childhood immunisation, which starts at 6 weeks of age.

Dr Petousis-Harris and her research team will investigate the effectiveness of providing pregnant women a dose of whooping cough booster vaccine to prevent or lessen the disease in their infants. The study will use data for all births between 2011–2013, all infants who were diagnosed with whooping cough and whether or not their mothers received the vaccine in pregnancy. Knowledge from this research will help inform the New Zealand immunisation programme and will contribute to the control of whooping cough.

Ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Scoop Business: Fletcher To Close Its Christchurch Insulation Plant, Cut 29 Jobs

Fletcher Building, New Zealand’s largest listed company, will close its Christchurch insulation factory, as it consolidates its Tasman Insulations operations in a “highly competitive market”. More>>

ALSO:

Scoop Business: Novartis Adds Nine New Treatments Under Pharmac Deal

Novartis New Zealand, the local unit of the global pharmaceuticals firm, has added nine new treatments in a far-ranging agreement with government drug buying agency, Pharmac. More>>

ALSO:

Crown Accounts: English Wary On Tax Take, Could Threaten Surplus

Finance Minister Bill English is warning the tax take may come in below forecast in the current financial year, as figures released today confirm it was short by nearly $1 billion in the year to June 30 and English warned of the potential impact of slumping receipts from agricultural exports. More>>

ALSO:

Auckland Outage: Power Mostly Restored Overnight

Vector wishes to advise that all but 324 customers have been restored overnight. These customers are spread throughout the network in small pockets. The main St Johns feeder was restored around midnight allowing most of the customers in all affected areas to have power this morning. More>>

ALSO:

Half Empty: Dairy Prices Drop To Lowest Since August 2009

Dairy product prices fell to the lowest level in more than five years in the latest GlobalDairyTrade auction, led by declines in butter milk powder and whole milk powder. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand

Mosh Social Media
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news